Received USD 3.5 million milestone fee from Maruho of Japan for GI301
GI Innovation received a USD 3.5 million milestone fee from Japan's Maruho on Nov 16, 2026, after the first patient was dosed in a Phase 2 trial in Japan.
358570 · KOSDAQ · Based on DART filings
1 total · 20 per page
GI Innovation received a USD 3.5 million milestone fee from Japan's Maruho on Nov 16, 2026, after the first patient was dosed in a Phase 2 trial in Japan.
Get app alerts for new disclosures from GI Innovation Inc..